Tirzepatide Manufacturing with Continuous Flow and Nanofiltration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for producing tirzepatide, a GIP/GLP1 dual agonist, face challenges in achieving large-scale commercial production with high purity and efficiency, while minimizing waste streams and avoiding harsh reaction conditions, and there is a need for environmentally friendly and safe manufacturing methods.
Innovation Solution
The development of novel intermediates and processes that include orthogonal protection of lysine with MTT, continuous flow synthesis, and the use of nanofiltration for purification, along with chromatographic methods to enhance purity and reduce waste, using ceramic membranes for aggressive solvents, and chiral HPLC-ESI-MS/MS for determining chiral purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of substance
If traditional peptide synthesis processes are used, then tirzepatide can be produced, but the process requires multiple purification steps and generates significant waste streams
Solution Approach 1:
The patent extracts and removes unnecessary purification steps from the traditional synthesis process by implementing telescoped reactions where intermediate purification is eliminated. The process integrates multiple reaction steps into a continuous flow system, extracting only the essential purification operations while removing redundant steps that generate waste.
Solution Approach 2:
The patent merges multiple reaction and purification steps into integrated continuous flow processes. By combining synthesis, protection group removal, and purification operations into a single telescoped process, the patent reduces the total number of discrete steps and minimizes waste stream generation while maintaining productivity.
2Productivity
If harsh reaction conditions are used to achieve high conversion, then reaction efficiency improves, but peptide degradation and side reactions increase
Solution Approach 1:
The patent changes the parameters of the reaction conditions by implementing continuous flow chemistry with precise control of temperature, pressure, and residence time. This allows optimization of reaction efficiency while maintaining peptide stability through controlled parameter adjustments rather than harsh conditions.
Solution Approach 2:
The patent replaces traditional batch reaction mechanics with continuous flow mechanics. This substitution enables better control over reaction parameters, improved heat and mass transfer, and reduced side reactions while maintaining high conversion efficiency through continuous processing.
3Manufacturing precision
If multiple protection groups are used to ensure selective reactions, then selectivity improves, but the number of deprotection steps and process complexity increase
Solution Approach 1:
The patent applies local quality by using site-specific protection strategies where protection groups are placed only where needed for selectivity. The continuous flow process enables localized deprotection and reaction steps, reducing the overall number of protection/deprotection cycles while maintaining manufacturing precision.
Solution Approach 2:
The patent implements preliminary action by pre-installing orthogonal protection groups on amino acids before peptide assembly. This preliminary protection strategy enables selective deprotection and coupling steps in the continuous flow process, reducing the total number of steps required while maintaining high selectivity.
4Adaptability or versatility
If batch processing is used for flexibility, then process adaptability improves, but production time and resource intensity increase
Solution Approach 1:
The patent implements continuity of useful action by transitioning from batch to continuous flow processing. The continuous flow system maintains uninterrupted reaction and purification operations, eliminating idle times between batch cycles while maintaining process flexibility through modular design and adjustable parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The improved processes achieve high purity and yield with reduced waste, enabling efficient large-scale production of tirzepatide, and provide a cost-effective, environmentally friendly manufacturing process with enhanced safety and reduced resource intensity.
Implementation Method 1
The reaction mixture is then subjected to nanofiltration to remove the resin and purify the peptide
Implementation Method 2
chromatographic methods to enhance purity and reduce waste
Implementation Method 3
chiral HPLC-ESI-MS/MS for determining chiral purity
Implementation Method 4
chiral HPLC-ESI-MS/MS for determining chiral purity
Data Source
AI summary
The present invention provides novel intermediates and processes useful in the manufacture of tirzepatide, or a pharmaceutically acceptable salt thereof.